Pneumonia News and Research

Latest Pneumonia News and Research

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Connie Houtz didn't think covid would be that bad. She'd seen many people in this rural hamlet in central Pennsylvania get infected yet recover within a few days. She did not get vaccinated because she worried about how a new vaccine, developed in record time, might affect her heart condition.

1 Apr 2022

Lung abnormalities may remain detectable long after COVID-19 pneumonia

Some people recovering from COVID-19 pneumonia have CT evidence of damage to their lungs that persists a full year after the onset of symptoms, according to a new study published in the journal Radiology.

30 Mar 2022

Study investigates recombinant SARS-CoV-2 variants in immunocompromised individuals

Researchers identified the recombination of two SARS-CoV-2 variants.

28 Mar 2022

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

A recent study investigated the disease severity of SARS-CoV-2 Omicron BA.2 infection among Hong Kong children.

28 Mar 2022

The effects of severe COVID-19 on the lungs after one year

While short-term lung damage has been reported in patients hospitalized with pneumonia caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is little data on the more chronic sequelae of this condition. A new research paper summarizes data from patients seen one year from discharge.

27 Mar 2022

Tuberculosis infection protects mice against COVID-19

To study if prior Mtb infection affects the response to CoV2 infection, K18-hACE2 (ACE2) and C57BL/6 (B6) mice were infected with Mtb, and post thirty days, were exposed to CoV2.

27 Mar 2022

CDK6: a potential drug target for severe COVID-19

Researchers identify a methodology and workflow to repurpose drugs against the cyclin-dependent kinase 6 target gene of SARS-CoV-2.

27 Mar 2022

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Antibiotic resistance is a growing problem worldwide that threatens the efficacy of available treatments and can lead to extended hospital stays and increased mortality.

24 Mar 2022

Breathlessness and fatigue most common in self reported long-COVID

A new systematic review and meta-analysis posted to the medRxiv* preprint server has focussed on investigating the respiratory outcomes and functional recovery of patients eight weeks post-hospitalization with COVID-19 disease.

24 Mar 2022

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.

23 Mar 2022

Discovery of helpful proteins in the lung could lead to new treatment for respiratory failure

Scientists have discovered a new family of helpful proteins in the lung, with the finding potentially paving the way for a new course of treatment for patients with respiratory failure.

23 Mar 2022

Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes

Researchers conducted an umbrella review and meta-analysis of the RAAS inhibitors' impact on COVID-19 clinical outcomes.

23 Mar 2022

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Researchers performed an in situ analysis to evaluate the correlation between CD48 expression and COVID-19.

22 Mar 2022

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

In a recent study posted to the bioRxiv* preprint server, researchers conducted a phylogenetic investigation of the human parainfluenza type 3 virus strain (HPIV3) that caused an outbreak in South Korea amid the coronavirus disease 2019 (COVID-19) pandemic.

22 Mar 2022

Pneumonia News and Research

Latest Pneumonia News and Research

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Lung abnormalities may remain detectable long after COVID-19 pneumonia

Study investigates recombinant SARS-CoV-2 variants in immunocompromised individuals

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

The effects of severe COVID-19 on the lungs after one year

Tuberculosis infection protects mice against COVID-19

CDK6: a potential drug target for severe COVID-19

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Breathlessness and fatigue most common in self reported long-COVID

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Discovery of helpful proteins in the lung could lead to new treatment for respiratory failure

Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

Understanding how coronavirus, RS virus and rhinovirus affect children

Characteristics of super-spreaders of novel coronaviruses

Study finds out-of-pocket spending for health care after COVID-19 hospital stay

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Study finds co-infected individuals carrying two distinct lineages of SARS-CoV-2 in Argentina

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pneumonia News and Research

Latest Pneumonia News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in